Getinge AB ser. B (GETIb)

Stockholm
Currency in SEK
192.7
+1.9(+1.00%)
Closed
GETIb Scorecard
Full Analysis
Has raised its dividend for 5 consecutive years
Earnings results expected in 10 days
Fair Value
Day's Range
190.2193.7
52 wk Range
164.4240.2
Key Statistics
Edit
Prev. Close
190.8
Open
191.4
Day's Range
190.2-193.7
52 wk Range
164.4-240.2
Volume
1.01M
Average Volume (3m)
1.01M
1-Year Change
-12.09%
Book Value / Share
111.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GETIb Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
218.1
Upside
+13.18%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Getinge AB ser. B Company Profile

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Employees
11848
Market
Sweden

Compare GETIb to Peers and Sector

Metrics to compare
GETIb
Peers
Sector
Relationship
P/E Ratio
31.0x22.2x−0.6x
PEG Ratio
−1.240.000.00
Price/Book
1.7x2.5x2.6x
Price / LTM Sales
1.6x3.2x3.1x
Upside (Analyst Target)
10.1%17.6%53.0%
Fair Value Upside
Unlock7.1%8.0%Unlock

Analyst Ratings

3 Buy
6 Hold
1 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 218.1

(+13.18% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.21
Dividend Yield
2.31%
Industry Median 1.08%
Annualized payout
4.4000
Paid annually
5-Years Growth
+34.49%
Growth Streak

Earnings

Latest Release
Oct 18, 2024
EPS / Forecast
2.24 / 2.43
Revenue / Forecast
7.87B / 8.00B
EPS Revisions
Last 90 days

People Also Watch

60.78
EKTABs
0.00%
2.1020
SABE
+0.48%
162.20
UHR
+1.60%
554.40
LONN
+1.20%
86.40
TEPRF
+2.86%

FAQ

What Is the Getinge B (GETIb) Stock Price Today?

The Getinge B stock price today is 192.70

What Stock Exchange Does Getinge B Trade On?

Getinge B is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Getinge B?

The stock symbol for Getinge B is "GETIb."

Does Getinge B Pay Dividends? What’s The Current Dividend Yield?

The Getinge AB ser. B dividend yield is 2.28%.

What Is the Getinge B Market Cap?

As of today, Getinge B market cap is 52.49B.

What is Getinge B Earnings Per Share?

The Getinge B EPS is 6.21.

What Is the Next Getinge B Earnings Date?

Getinge B will release its next earnings report on Jan 27, 2025.

From a Technical Analysis Perspective, Is GETIb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.